⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23779683 | 1.00 | — | — | |
| SCHEMBL23779689 | 1.00 | — | — | |
| SCHEMBL23779681 | 1.00 | — | — | |
| SCHEMBL23779680 | 0.95 | — | — | |
| SCHEMBL23779690 | 0.95 | MEN1 (0.30) | — | |
| SCHEMBL23779696 | 0.95 | MEN1 (0.30) | — | |
| SCHEMBL23779694 | 0.95 | MEN1 (0.30) | — | |
| SCHEMBL23779695 | 0.95 | MEN1 (0.30) | — | |
| SCHEMBL23779682 | 0.90 | MEN1 (0.30) | — | |
| SCHEMBL23779692 | 0.90 | BLM (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12091491-B2 | Silylamine compound and latent curing agent comprising said silylamine compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2024-09-17 | — | — | US | disclosed |
| US-20220119583-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2022-04-21 | — | — | US | disclosed |
| EP-3875461-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | Koei Chemical Company, Limited (JP) | 2021-09-08 | — | — | EP | disclosed |